# Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation

> **NCT03490461** · — · COMPLETED · sponsor: **Yonsei University** · enrollment: 350 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Statin

## Key facts

- **NCT ID:** NCT03490461
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-22
- **Primary completion:** 2018-03-01
- **Final completion:** 2018-03-01
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03490461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03490461, "Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03490461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*